Canada markets open in 6 hours 24 minutes

AIM ImmunoTech Inc. (AIM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.8900-0.0200 (-2.20%)
At close: 04:00PM EST
0.9200 +0.03 (+3.37%)
After hours: 06:46PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 55.50M
Enterprise Value 18.53M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)416.41
Price/Book (mrq)0.91
Enterprise Value/Revenue 145.87
Enterprise Value/EBITDA -1.14

Trading Information

Stock Price History

Beta (5Y Monthly) -0.93
52-Week Change 3-57.62%
S&P500 52-Week Change 322.74%
52 Week High 33.0600
52 Week Low 30.8500
50-Day Moving Average 31.2676
200-Day Moving Average 31.8526

Share Statistics

Avg Vol (3 month) 3352.65k
Avg Vol (10 day) 3258.93k
Shares Outstanding 547.85M
Implied Shares Outstanding 6N/A
Float 847.29M
% Held by Insiders 11.38%
% Held by Institutions 115.19%
Shares Short (Dec. 30, 2021) 4856.58k
Short Ratio (Dec. 30, 2021) 41.87
Short % of Float (Dec. 30, 2021) 41.81%
Short % of Shares Outstanding (Dec. 30, 2021) 41.79%
Shares Short (prior month Nov. 29, 2021) 4797.42k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun. 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:44
Last Split Date 3Jun. 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-12,795.28%

Management Effectiveness

Return on Assets (ttm)-15.96%
Return on Equity (ttm)-27.96%

Income Statement

Revenue (ttm)127k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-8.30%
Gross Profit (ttm)-643k
EBITDA -15.48M
Net Income Avi to Common (ttm)-17.21M
Diluted EPS (ttm)-0.3780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.85M
Total Cash Per Share (mrq)0.79
Total Debt (mrq)144k
Total Debt/Equity (mrq)0.23
Current Ratio (mrq)49.59
Book Value Per Share (mrq)1.28

Cash Flow Statement

Operating Cash Flow (ttm)-11.07M
Levered Free Cash Flow (ttm)-8.25M